Well-Known Genus, Novel Method: A Post-Amgen Framework for Written Description & Enablement

Recent Federal Circuit decision draws a meaningful distinction between patents that claim a broad genus as the invention itself and those that claim a novel therapeutic method using a well‑known genus, signaling that method‑of‑use claims tied to specific treatments may face a narrower written‑description and enablement burden.... By: Knobbe Martens